Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

ACADIA Pharmaceuticals Inc.

TRADE

NASDAQ: ACADHealthcare / Biotechnology / USA
17.37-0.44-2.47%Vol 1 278 7301Y Perf -35.52%
Nov 14th, 2018 14:02
BID17.36 ASK17.39
Open18.13 Previous Close17.81
Pre-Market18.05 After-Trading18.00
 0.24 1.35%  0.19 1.07%
Target Price
31.88 
Analyst Rating
Strong Buy 1.25
Potencial %
83.22 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/50 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/69 
Growth Ranking
★★★     51.43
Insiders Shares Cnt. % 3/6/12M
100/100/80 
Income Ranking
 —    -
Market Cap (mil)2 172 
Earnings Rating
Price Range Ratio 52wk %
22.75 
Earnings Date

Today's Price Range

17.0218.18

 

52wk Range

12.7732.99

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-18.00%
3 Months
24.28%
6 Months
-6.95%
1 Year
-35.52%
3 Years
-49.19%
5 Years
-22.36%

Quotes

Name / TickerPriceChg.Chg.%
ACAD17.37-0.4400-2.47
AAPL186.41-5.8200-3.03
GOOG1 036.420.37000.04
MSFT104.57-2.3700-2.22
XOM76.89-1.1100-1.42
WFC51.75-0.9900-1.88
JNJ143.97-0.7100-0.49
FB142.900.74000.52
GE8.21-0.4000-4.65
JPM106.03-3.5600-3.25
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 5.60
Current Ratio 6.10
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin94.20
EBIT Margin-120.40
EBITDA Margin-119.00
Pre-tax Profit Margin-70 240.70
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 10.56
PS Ratios 11.35
Price to Cash Flow -
Price to Free Cash Flow -14.80
Cash Flow Per Share -1.27
Price to Tangible Book10.77
Book Value per Share1.79
Enterprise Value (in ths.)2 144 770
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-60.26
ROE last 12 Months -82.75
Return on Assets (5Y Avg) -50.32
ROA last 12 Months -73.09
Return on Capital (5Y Avg) -54.80
ROC last 12 Months -82.75
Return on invested Capital Q -25.46
Return on invested Capital Y-67.80
Assets Turnover0.20
Receivables Turnover6.40
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)207 798
Revenue per Share 1.66
Revenue Growth 3 Years 1 201.73
Revenue Growth 5 Years 268.98
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.58-0.5013.79
Q02 2018-0.45-0.51-13.33
Q01 2018-0.56-0.4421.43
Q04 2017-0.58-0.555.17
Q03 2017-0.63-0.5315.87
Q02 2017-0.71-0.5522.54
Q01 2017-0.73-0.721.37
Q04 2016-0.65-0.650.00
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.55-3.77Negative
12/2018 FY-2.014.74Positive
3/2019 QR-0.56-12.00Negative
12/2019 FY-1.75-12.90Negative
Next Report Date6th Nov 2018
Estimated EPS Next Report-0.57
Estimates Count6
EPS Growth Next 5 Years %13.60
Volume Overview
Volume1 278 730
Shares Outstanding (in ths.)125 070
Trades Count7 499
Dollar Volume21 399 700
Avg. Volume2 854 845
Avg. Weekly Volume1 930 255
Avg. Monthly Volume3 010 804
Avg. Quarterly Volume2 800 646

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

38%62%

Bearish Bullish

64%36%

Bearish Bullish

63%38%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (87.50 %)
7 (87.50 %)
5 (71.43 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (12.50 %)
1 (12.50 %)
2 (28.57 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.25
Strong Buy
1.25
Moderate Buy
1.57

There are no comments yet.

News

x